SciSparc Ltd.
SPRC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001611746
No open-market purchases or sales by SciSparc Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $296.4K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding SciSparc Ltd. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 7 | 6 | −1 |
| Shares | 473.4K | 164.2K | −309.2K (−65.3%) |
| Value | $1.01M | $129.5K | −$877.5K (−87.1%) |
New holders (3)
Institutions that held SciSparc Ltd. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| StoneX Group Inc. | 13,696 | $11.5K | 0.00% |
| Commonwealth Equity Services, LLC | 12,005 | $10.0K | 0.00% |
| Gradient Investments LLC | 75 | $0 | 0.00% |
Sold out (4)
Institutions that held SciSparc Ltd. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Armistice Capital, LLC | 335,000 | $714.0K |
| Citadel Advisors LLC | 19,807 | $41.0K |
| Citigroup Inc | 50 | $0 |
| Ahrens Investment Partners LLC | 1 | $0 |